Skip to main content
Fig. 5 | BMC Medical Genomics

Fig. 5

From: A novel defined risk signature based on pyroptosis-related genes can predict the prognosis of prostate cancer

Fig. 5

The signature has high accuracy and applicability. 1, 3, 5-year ROC curve for risk score-based patients in TCGA cohort (A) and GSE70769 cohort (B). C 1, 3, 5-year ROC curve of overall survival risk for risk score-based patients in TCGA cohort. D The ROC curve for the 3-year progression-free survival prediction of risk signature and the other four prognostic signatures. Results from PCA in TCGA cohort (E) and GSE70769 cohort (F) showed that risk score well divided the samples into two subgroups

Back to article page